Update on the management of rosacea

References

• CribierBMedical history of the representation of rosacea in the 19th centuryJ Am Acad Dermatol2013696 Suppl 1S2S1424229633
   PubMed Web of Science ®Google Scholar
• CrawfordGHPelleMTJamesWDRosacea: I. Etiology pathogenesis, and subtype classificationJ Am Acad Dermatol200451332734115337973
   PubMed Web of Science ®Google Scholar
• WilkinJDahlMDetmarMStandard classification of rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosaceaJ Am Acad Dermatol200246458458711907512
   PubMed Web of Science ®Google Scholar
• AbramKSilmHOonaMPrevalence of rosacea in an Estonian working population using a standard classificationActa Derm Venereol201090326927320526544
   PubMed Web of Science ®Google Scholar
• TanJBergMRosacea: current state of epidemiologyJ Am Acad Dermatol2013696 Suppl 1S27S3524229634
   PubMed Web of Science ®Google Scholar
• LomholtGPrevalence of skin diseases in a population; a census study from the Faroe IslandsDan Med Bull1964111714120983
   PubMedGoogle Scholar
• RomanowiczMStephensonJJDel RossoJQLenhartGHealthcare utilization and costs of patients with rosacea in an insured populationJ Drugs Dermatol200871414918246697
   PubMed Web of Science ®Google Scholar
• McAleerMAFitzpatrickPPowellFCPapulopustular rosacea: prevalence and relationship to photodamageJ Am Acad Dermatol2010631333920462665
   PubMed Web of Science ®Google Scholar
• SchaeferIRustenbachSJZimmerLAugustinMPrevalence of skin diseases in a cohort of 48,665 employees in GermanyDermatology2008217216917218525204
   PubMed Web of Science ®Google Scholar
• AugustinMHerbergerKHintzenSHeigelHFranzkeNSchaferIPrevalence of skin lesions and need for treatment in a cohort of 90,880 workersBr J Dermatol2011165486587321623753
   PubMed Web of Science ®Google Scholar
• BergMLidenSAn epidemiological study of rosaceaActa Derm Venereol19896954194232572109
   PubMed Web of Science ®Google Scholar
• GuttmanCRosacea prevalence underestimatedDermatology Times2006274857
   Google Scholar
• TüzünYWolfRKutlubayZKarakuşOEnginBRosacea and rhinophymaClin Dermatol2014321354624314376
   PubMed Web of Science ®Google Scholar
• VieiraACMannisMJOcular rosacea: common and commonly missedJ Am Acad Dermatol2013696 Suppl 1S36S4124229635
   PubMed Web of Science ®Google Scholar
• SteinhoffMBuddenkotteJAubertJClinical, cellular and molecular aspects in the pathophysiology of rosaceaJ Investig Dermatol Symp Proc2011151211
   PubMedGoogle Scholar
• SteinhoffMSchauberJLeydenJNew insights into rosacea pathophysiology: a review of recent findingsJ Am Acad Dermatol2013696 Suppl 1S15S2624229632
   PubMed Web of Science ®Google Scholar
• SchauberJGalloRLThe vitamin D pathway: a new target for control of the skin’s immune response?Exp Dermatol200817863363918573153
   PubMed Web of Science ®Google Scholar
• Meyer-HoffertUSchroderJMEpidermal proteases in the pathogenesis of rosaceaJ Investig Dermatol Symp Proc20111511623
   Google Scholar
• GeorgalaSKatoulisACKylafisGDKoumantaki-MathioudakiEGeorgalaCAroniJIncreased density of Demodex folliculorum and evidence of delayed hypersensistivity reaction in subjects with papulopustular rosaceaJ Eur Acad Dermatol Venereol200115544144411763386
   PubMed Web of Science ®Google Scholar
• HolmesADPotential role of microorganisms in the pathogenesis of rosaceaJ Am Acad Dermatol20136961025103224011460
   PubMed Web of Science ®Google Scholar
• AubdoolAABrainSDNeurovascular aspects of skin neurogenic inflammationJ Investig Dermatol Symp Proc20111513339
   Google Scholar
• MooreAKempersSMirakawaGLong-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label studyJ Drugs Dermatol2014131566124385120
   PubMed Web of Science ®Google Scholar
• FowlerJJarrattMMooreAOnce-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicenter, randomized and vehicle-controlled studiesBr J Dermatol2012166363364122050040
   PubMed Web of Science ®Google Scholar
• JacksonJMFowlerJMooreAImprovement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosaceaJ Drugs Dermatol201413669970424918560
   PubMed Web of Science ®Google Scholar
• ShanlerSDOndoALSuccessful treatment of the erythema and flushing of rosacea using a topically applied selective alpha 1-adrenergic receptor agonist, oxymetazolineArch Dermatol2007143111369137118025359
   PubMedGoogle Scholar
• ThomasKYelvertonCBYentzerBABalkrishnanRFleischerABJrFeldmanSRThe cost-effectiveness of rosacea treatmentsJ Dermatol Treat20092027275
   PubMed Web of Science ®Google Scholar
• ElewskiBEFleischerABJrPariserDMA comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment for papulopustular rosacea: results of a randomized trialArch Dermatol2003139111444145014623704
   PubMedGoogle Scholar
• WolfJEJrKerroucheNArsonnaudSEfficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosaceaCutis2006774 Suppl31116706244
   PubMed Web of Science ®Google Scholar
• TrumboreMWGoldsteinJAGurgeRMTreatment of papulopustular rosacea with sodium sulfacetamide 10% – sulfur 5% emollient foamJ Drugs Dermatol20098329930419271381
   PubMedGoogle Scholar
• Del RossoJQThiboutotDGalloRConsensus recommendations from the American Acne and Rosacea Society on the management of rosacea. Part 2: a status report on topical agentsCutis201392627728424416742
   PubMed Web of Science ®Google Scholar
• KarabulutAAIzol SerelBEksiogluHMA randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosaceaJ Eur Acad Dermatol Venereol200822672973418328059
   PubMed Web of Science ®Google Scholar
• CrawfordKMRussBBostromPPimecrolimus for treatment of acne rosaceaSkinmed20054314715015891250
   PubMedGoogle Scholar
• KocaRAltinyazarHCAnkaraliHMuhtarSTekinNSCinarSA comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trialClin Exp Dermatol201035325125619594764
   PubMed Web of Science ®Google Scholar
• KocakMYağliSVahapoğluGEksioğluMPermethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea: A randomized double-blind placebo-controlled studyDermatology2002205326527012399675
   PubMed Web of Science ®Google Scholar
• SignoreRJA pilot study of 5 percent permethrin cream versus 0.75 percent metronidazole gel in acne rosaceaCutis19955631771798565604
   PubMed Web of Science ®Google Scholar
• AllenKJDavisCLBillingsSDMousdicasNRecalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrinCutis200780214915117944176
   PubMed Web of Science ®Google Scholar
• SteinLKircikLFowlerJEfficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studiesJ Drugs Dermatol201413331632324595578
   PubMed Web of Science ®Google Scholar
• ForstingerCKittlerHBinderMTreatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin creamJ Am Acad Dermatol1999415 Pt 177577710534645
   PubMed Web of Science ®Google Scholar
• PariserDMMeinkingTLBellMRyanWGTopical 0.5% ivermectin lotion for treatment of head liceN Engl J Med2012367181687169323113480
   PubMed Web of Science ®Google Scholar
• FilhoPAHazarbassanovRMGrisoliaABPazosHBKaisermanIGomesJAThe efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for Demodex sppBr J Ophthalmol201195689389521349944
   PubMed Web of Science ®Google Scholar
• BrenemanDSavinRVandePolCVamvakiasGLevySLeydenJDouble-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosaceaInt J Dermatol200443538138715117375
   PubMed Web of Science ®Google Scholar
• LeydenJJRandomized, phase 2, dose-ranging study in the treatment of rosacea with encapsulated benzoyl peroxide gelJ Drugs Dermatol201413668568824918558
   PubMed Web of Science ®Google Scholar
• EmerJWaldorfHBersonDBotanicals and anti-inflammatories: natural ingredients for rosaceaSemin Cutan Med Surg201130314815521925368
   PubMed Web of Science ®Google Scholar
• BaldwinHBersonDVitaleMYatskayerMChenNOresajoCClinical effects of a novel topical composition on persistent redness observed in patients who had been successfully treated with topical or oral therapy for papulopustular rosaceaJ Drugs Dermatol201413332633124595579
   PubMed Web of Science ®Google Scholar
• FerrariADiehlCEvaluation of the efficacy and tolerance of a topical gel with 4% quassia extract in the treatment of rosaceaJ Clin Pharmacol2012521848821343346
   PubMed Web of Science ®Google Scholar
• SchlesingerTEPowellCREfficacy and tolerability of low molecular weight hyaluronic acid sodium salt 0.2% cream in rosaceaJ Drugs Dermatol201312666466723839183
   PubMed Web of Science ®Google Scholar
• GariboldiSPalazzoMZanobbioLLow molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4J Immunol200818132103211018641349
   PubMed Web of Science ®Google Scholar
• Del RossoJQWebsterGFJacksonMTwo randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosaceaJ Am Acad Dermatol200756579180217367893
   PubMed Web of Science ®Google Scholar
• KanadaKNNakatsujiTGalloRLDoxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidinJ Invest Dermatol201213251435144222336948
   PubMed Web of Science ®Google Scholar
• LaytonAThiboutotDEmerging therapies in rosaceaJ Am Acad Dermatol2013696 Suppl 1S57S6524229638
   PubMed Web of Science ®Google Scholar
• Del RossoJQThiboutotDGalloRConsensus recommendations from the American Acne and Rosacea Society on the management of rosacea. Part 3: a status report on systemic therapiesCutis2014931182824505581
   PubMed Web of Science ®Google Scholar
• Del RossoJQSchlessingerJWerschlerPComparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosaceaJ Drugs Dermatol20087657357618561589
   PubMed Web of Science ®Google Scholar
• Del RossoJQThe ORCA (Oracea for Rosacea: a Community-based Assessment) trial: a large-scale, phasae 4 trial in papulopustular rosaceaCutis2010865 Suppl4621229825
   PubMedGoogle Scholar
• WebsterGFAn open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads)Cutis2010865 Suppl71521229826
   PubMedGoogle Scholar
• AlexisAFWebsterGPrestonNJCaveneySWGottschalkRWEffectiveness and safety of once-daily doxycycline capsules as monotherapy in patients with rosacea: an analysis by Fitzpatrick skin typeJ Drugs Dermatol201211101219122223134987
   PubMed Web of Science ®Google Scholar
• JacksonJMKircikLHLorenzDJEfficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosaceaJ Drugs Dermatol201312329229823545911
   PubMed Web of Science ®Google Scholar
• SobolewskaBDoychevaDDeuterCPfefferISchallerMZierhutMTreatment of ocular rosacea with once-daily low-dose doxycyclineCornea201433325726024452213
   PubMed Web of Science ®Google Scholar
• PfefferIBorelliCZierhutMSchallerMTreatment of ocular rosacea with 40 mg doxycycline in a slow release formJ Dtsch Dermatol Ges201191190490721672164
   PubMed Web of Science ®Google Scholar
• MantelliFDi ZazzoASacchettiMDianzaniCLambiaseABoniniSTopical azithromycin as a novel treatment for ocular rosaceaOcul Immunol Inflamm201321537137723875944
   PubMed Web of Science ®Google Scholar
• ThiboutotDMFleischerABDel RossoJQRichPA multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapyJ Drugs Dermatol20098763964819588640
   PubMed Web of Science ®Google Scholar
• FowlerJFJrCombination effect of anti-inflammatory dose doxycycline (40-mg doxycycline, USP monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosaceaJ Drugs Dermatol20076664164517668530
   PubMedGoogle Scholar
• ModiSHartingMRosenTAzithromycin as an alternative rosacea therapy when tetracyclines prove problematicJ Drugs Dermatol20087989889919112809
   PubMedGoogle Scholar
• KimJHOhYSChoiEHOral azithromycin for treatment of intractable rosaceaJ Korean Med Sci201126569469621532865
   PubMed Web of Science ®Google Scholar
• SehgalVNSharmaSSardanaKRosacea/acne rosacea: efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointmentJ Eur Acad Dermatol Venereol200822111366136818435734
   PubMed Web of Science ®Google Scholar
• PyeRJBurtonJLTreatment of rosacea by metronidazoleLancet1976179711211121258258
   PubMed Web of Science ®Google Scholar
• ParkHDel RossoJQUse of oral isotretinoin in the management of rosaceaJ Clin Aesthet Dermatol201149546121938271
   PubMedGoogle Scholar
• GollnickHBlume-PeytaviUSzaboELSystemic isotretinoin in the treatment of rosacea – doxycycline- and placebo-controlled, randomized clinical studyJ Dtsch Dermatol Ges20108750551520337772
   PubMed Web of Science ®Google Scholar
• HoferTContinuous ‘microdose’ isotretinoin in adult recalcitrant rosaceaClin Exp Dermatol200429220420514987287
   PubMed Web of Science ®Google Scholar
• PalmerRASidhuSGoodwinPG‘Microdose’ isotretinoinBr J Dermatol2000143120520610886171
   PubMed Web of Science ®Google Scholar
• PavlisMBLieblichLIsotretinoin-induced skin fragility in a teenaged athlete: a case reportCutis2013921333423961523
   PubMed Web of Science ®Google Scholar
• HolmesSCThomsonJIsotretinoin and skin fragilityBr J Dermatol199513211657756141
   PubMed Web of Science ®Google Scholar
• RubensteinRRoenigkHHJrStegmanSJHankeCWAtypical keloids after dermabrasion of patients taking isotretinoinJ Am Acad Dermatol1986152 Pt 12802853018052
   PubMed Web of Science ®Google Scholar
• ZachariaeHDelayed wound healing and keloid formation following argon laser treatment or dermabrasion during isotretinoin treatmentBr J Dermatol198811857037062969261
   PubMed Web of Science ®Google Scholar
• ChandrashekarBSVarshaDVVasanthVMaduraCRajashekarMLSafety of performing invasive acne scar treatment and laser hair removal in patients on oral isotretinoin: a retrospective study of 110 patientsInt J Dermatol201453101281128525039864
   PubMed Web of Science ®Google Scholar
• YoonJHParkEJKwonIHConcomitant use of an infrared fractional laser with low-dose isotretinoin for the treatment of acne and acne scarsJ Dermatolog Treat201425214214623336106
   PubMed Web of Science ®Google Scholar
• SharquieKENajimRAAl-SalmanHNOral zinc sulfate in the treatment of rosacea: a double-blind, placebo controlled studyInt J Dermatol200645785786116863527
   PubMed Web of Science ®Google Scholar
• BamfordJTGessertCEHallerIVKrugerKJohnsonBPRandomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosaceaInt J Dermatol201251445946222435439
   PubMed Web of Science ®Google Scholar
• AndersonRRParishJASelective photothermolysis: precise microsurgery by selective absorption of pulsed radiationScience198322045965245276836297
   PubMed Web of Science ®Google Scholar
• BenciniPLTourlakiADe GiorgiVGalimbertiMLaser use for cutaneous vascular alterations of cosmetic interestDermatol Ther201225434035122950561
   PubMed Web of Science ®Google Scholar
• CameronHIbbotsonSHFergusonJDaweRSMoseleyHA randomized, blinded, controlled study of the clinical relevance of matching pulse duration to thermal relaxation time when treating facial telangiectasiaLasers Med Sci2005203−411712116151607
   PubMed Web of Science ®Google Scholar
• TanghettiEDel RossoJQThiboutotDConsensus recommendations from the American acne and rosacea society on the management of rosacea. Part 4: a status report on physical modalities and devicesCutis2014932717624605343
   PubMed Web of Science ®Google Scholar
• MansouriYGoldenbergGDevices and topical agents for rosacea managementCutis2014941212525101340
   PubMed Web of Science ®Google Scholar
• ArndtKAArgon laser therapy of small cutaneous vascular lesionsArch Dermatol198211842202246461295
   PubMedGoogle Scholar
• LaubeSLaniganSWLaser treatment of rosaceaJ Cosmet Dermatol20021418819517147538
   PubMedGoogle Scholar
• ErcegAde JongEMvan de KerkhofPCSeygerMMThe efficacy of pulsed dye laser treatment for inflammatory skin diseases: a systematic reviewJ Am Acad Dermatol201369460961523711766
   PubMed Web of Science ®Google Scholar
• ButterwickKJButterwickLSHanALaser and light therapies for acne rosaceaJ Drugs Dermatol200651353916468290
   PubMedGoogle Scholar
• BernsteinEFKligmanARosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laserLasers Surg Med200840423323918412227
   PubMed Web of Science ®Google Scholar
• LoweNJBehrKLFitzpatrickRGoldmanMRuiz-EsparzaJFlash lamp pumped dye laser for rosacea-associated telangiectasia and erythemaJ Dermatol Surg Oncol19911765225251828257
   PubMedGoogle Scholar
• AlamMDoverJSArndtKATreatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura thresholdDermatol Surg200329768168512828690
   PubMed Web of Science ®Google Scholar
• JasimZFWooWKHandleyJMLong-pulsed (6-ms) pulsed dye laser treatment of rosacea-associated telangiectasia using subpurpuric clinical thresholdDermatol Surg2004301374014692924
   PubMed Web of Science ®Google Scholar
• TanSRTopeWDPulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of lifeJ Am Acad Dermatol200451459259915389196
   PubMed Web of Science ®Google Scholar
• TanSTBialostockiAArmstrongJRPulsed dye laser therapy for rosaceaBr J Plast Surg200457430331015145732
   PubMedGoogle Scholar
• Lonne-RahmSNordlindKEdstromDWRosAMBergMLaser treatment of rosacea: a pathoetiological studyArch Dermatol2004140111345134915545543
   PubMedGoogle Scholar
• Togsverd-BoKWiegellSRWulfHCHaedersdalMShort and limited effect of long-pulse dye laser alone and in combination with photodynamic therapy for inflammatory rosaceaJ Eur Acad Dermatol Venereol200923220020118452529
   PubMed Web of Science ®Google Scholar
• KimTGRohHJChoSBLeeJHLeeSJOhSHEnhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: a randomized, prospective, split-face trialBr J Dermatol2011164357357921143465
   PubMed Web of Science ®Google Scholar
• KashlanLGraberEMArndtKAHair dryer use to optimize pulsed dye laser treatment in rosacea patientsJ Clin Aesthet Dermatol201256414422768356
   PubMedGoogle Scholar
• LaniganSReduction of pain in the treatment of vascular lesions with a pulsed dye laser and pneumatic skin flatteningLasers Med Sci200924461762019050824
   PubMed Web of Science ®Google Scholar
• PiccoloDDi MarcantonioDCrismanGUnconventional use of intense pulsed lightBiomed Res Int2014201461820625276803
   PubMed Web of Science ®Google Scholar
• AngermeierMCTreatment of facial vascular lesions with intense pulsed lightJ Cutan Laser Ther1999129510011357295
   PubMedGoogle Scholar
• TaubAFTreatment of rosacea with intense pulsed lightJ Drugs Dermatol20032325425912848109
   PubMedGoogle Scholar
• MarkKASparacioRMVoigtAMarenusKSarnoffDSObjective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatmentDermatol Surg200329660060412786702
   PubMed Web of Science ®Google Scholar
• SchroeterCAHaff-von BelowSNeumannHAEffective treatment of rosacea using intense pulsed light systemsDermatol Surg200531101285128916188180
   PubMed Web of Science ®Google Scholar
• PapageorgiouPClaytonWNorwoodSChopraSRustinMTreatment of rosacea with intense pulsed light: significant improvement and long-lasting resultsBr J Dermatol2008159362863218565174
   PubMed Web of Science ®Google Scholar
• KassirRKolluruAKassirMIntense pulsed light for the treatment of rosacea and telangiectasiasJ Cosmet Laser Ther201113521622221848421
   PubMed Web of Science ®Google Scholar
• SperberBRWallingHWArpeyCFWhitakerDCVesiculobullous eruption from intense pulsed light treatmentDermatol Surg200531334534815841640
   PubMed Web of Science ®Google Scholar
• TaubAFDevitaEFSuccessful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequencyJ Clin Aesthet Dermatol200811374021103309
   PubMedGoogle Scholar
• NeuhausIMZaneLTTopeWDComparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosaceaDermatol Surg200935692092819397667
   PubMed Web of Science ®Google Scholar
• LaneJEKhachemouneAUse of intense pulsed light to treat refractory granulomatous rosaceaDermatol Surg201036457157320402938
   PubMed Web of Science ®Google Scholar
• LiuJLiuJRenYLiBLuSComparative efficacy of intense pulsed light for different erythema associated with rosaceaJ Cosmet Laser Ther201416632432725151911
   PubMed Web of Science ®Google Scholar
• LimHSLeeSCWonYHLeeJBThe efficacy of intense pulsed light for treating erythematotelangiectatic rosacea is related to severity and ageAnn Dermatol201426449149525143679
   PubMed Web of Science ®Google Scholar
• TsunodaKTakahashiKOginoNYoshidaAAkasakaTTreatment of facial telangiectasia with a small spot of intense pulsed light: a case series of three patientsJ Dermatol201441763864124931642
   PubMed Web of Science ®Google Scholar
• PelleMTCrawfordGHJamesWDRosacea: II. TherapyJ Am Acad Dermatol200451449951215389184
   PubMed Web of Science ®Google Scholar
• BassichisBASwamyRDayanSHUse of the KTP laser in the treatment of rosacea and solar lentiginesFacial Plast Surg2004201778315034818
   PubMedGoogle Scholar
• BecherGLCameronHMoseleyHTreatment of superficial vascular lesions with the KTP 532-nm laser: experience with 647 patientsLasers Med Sci201429126727124401943
   PubMed Web of Science ®Google Scholar
• ClarkCCameronHMoseleyHFergusonJIbbotsonSHTreatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laserLasers Med Sci20041911515316851
   PubMed Web of Science ®Google Scholar
• MillerATreatment of erythematotelangiectatic rosacea with a KTP YAG laserJ Drugs Dermatol20054676076216302564
   PubMedGoogle Scholar
• WestTBAlsterTSComparison of the long-pulse dye (590−595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasiasDermatol Surg19982422212269491116
   PubMed Web of Science ®Google Scholar
• GeorgeJBensafiASchmittAMValidation of a non-contact technique for local skin temperature measurementsSkin Res Technol200814438138418937770
   PubMed Web of Science ®Google Scholar
• SalemSAAbdel FattahNSTantawySMEl-BadawyNMAbd El-AzizYANeodymium-yttrium aluminum garnet laser versus pulsed dye laser in erythemato-telangiectatic rosacea: comparison of clinical efficacy and effect on cutaneous substance (P) expressionJ Cosmet Dermatol201312318719423992160
   PubMed Web of Science ®Google Scholar
• AlamMVoravutinonNWarychaMComparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: a double-blind randomized controlled trialJ Am Acad Dermatol201369343844323688651
   PubMed Web of Science ®Google Scholar
• MattonGPickrellKHugerWPoundEThe surgical treatment of rhinophyma: an analysis of 57 casesPlast Reconstr Surg196230403414
   Google Scholar
• LimRYContact Nd:YAG laser excision of rhinophymaW V Med J199490262638165809
   PubMedGoogle Scholar
• WenigBLWeingartenRTExcision of rhinophyma with Nd:YAG laser: a new techniqueLaryngoscope19931031 Pt 11011038421411
   PubMed Web of Science ®Google Scholar
• ApfelbergDBSide effects, sequelae, and complications of carbon dioxide laser resurfacingAesthet Surg J199717636537219328086
   PubMedGoogle Scholar
• CampolmiPBonanPCannarozzoGHighlights of thirty-year experience of CO2 laser use at the Florence (Italy) department of dermatologyScientificWorldJournal2012201254652822593693
   PubMed Web of Science ®Google Scholar
• ShapshaySMStrongMSAnastasiGWVaughanCWRemoval of rhinophyma with the carbon dioxide laser: a preliminary reportArch Otolaryngol198010652572596445187
   PubMedGoogle Scholar
• MadenVFergusonJEAugustPJCarbon dioxide laser treatment of rhinophyma: a review of 124 patientsBr J Dermatol2009161481481819624541
   PubMed Web of Science ®Google Scholar
• LimSWLimSWBekhorPRhinophyma: carbon dioxide laser with computerized scanner is still an outstanding treatmentAustralas J Dermatol200950428929319916975
   PubMed Web of Science ®Google Scholar
• CravoMCanelasMMCardosoJCVieiraRFigueiredoACombined carbon dioxide laser and bipolar electrocoagulation: another option to treat rhinophymaJ Dermatol Treat2009203146148
   Web of Science ®Google Scholar
• RaiSMadanVTreatment of metophyma with the carbon dioxide laserDermatol Surg201238351351522385227
   PubMed Web of Science ®Google Scholar
• MoreiraALeiteIGuedesRBaptistaAMotaGSurgical treatment of rhinophyma using carbon dioxide (CO2) laser and pulsed dye laser (PDL)J Cosmet Laser Ther2010122737620331343
   PubMed Web of Science ®Google Scholar
• SerowkaKLSaediNDoverJSZacharyCBFractionated ablative carbon dioxide laser for the treatment of rhinophymaLasers Surg Med201446181224123064
   PubMed Web of Science ®Google Scholar
• SinghSPetersonJDFriedmanPMManagement of mild to moderate rhinophyma using ablative fractional photothermolysisDermatol Surg20133971110111323773176
   PubMed Web of Science ®Google Scholar
• CarradinoBDi LorenzoSMoschellaF“Downward steps techinique” with CO2 ultrapulsed laser for the treatment of rhinophyma: our protocolActa Chir Plast2013551161824188317
   PubMedGoogle Scholar
• BassiACampolmiPDindelliMLaser surgery in rhinophymaG Ital Dermatol Venereol9182014 Epub ahead of print
   Web of Science ®Google Scholar
• LazzeriDLarcherLHuemerGMSurgical correction of rhinophyma: comparison of two methods in a 15-year-long experienceJ Craniomaxillofac Surg201341542943623232283
   PubMed Web of Science ®Google Scholar
• OrensteinAHaikJTamirJTreatment of rhinophyma with Er:YAG laserLasers Surg Med200129323023511573224
   PubMed Web of Science ®Google Scholar
• GoonPKDalalMPeartFCThe gold standard for decortication of rhinophyma: combined erbium-YAG/CO2 laserAesthetic Plast Surg200428645646015625593
   PubMed Web of Science ®Google Scholar
• FincherEFGladstoneHBUse of a dual-mode erbium:YAG laser for the surgical correction of rhinophymaArch Facial Plast Surg20046426727115262723
   PubMedGoogle Scholar
• NohSSinJUJungJYLeeJHA case of sebaceous hyperplasia maintained on low-dose isotretinoin after carbon dioxide laser treatmentIn J Dermatol2014532e151e153
   Web of Science ®Google Scholar
• McDonaldSKGohMSChongAHSuccessful treatment of cyclosporine-induced sebaceous hyperplasia with oral isotretinoin in two renal transplant recipientsAustralas J Dermatol201152322723021834824
   PubMed Web of Science ®Google Scholar
• YuCShahsavariMStevensGLiskanichRHorowitzDIsotretinoin as monotherapy for sebaceous hyperplasiaJ Drugs Dermatol20109669970120645535
   PubMed Web of Science ®Google Scholar
• Del RossoJQAdvances in understanding and managing rosacea. Part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosaceaJ Clin Aesthet Dermatol201253263622468177
   PubMedGoogle Scholar
• MoustafaFLewallenRSFeldmanSRThe psychosocial impact of rosacea and the influence of current management optionsJ Am Acad Dermatol201471597398024993600
   PubMed Web of Science ®Google Scholar
• GuptaMAGuptaAKChenSJJohnsonAMComorbidity of rosacea and depression; an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey – Outpatient department data collected by the US National Center for Health Statistics from 1995 to 2002Br J Dermatol200515361176118116307654
   PubMed Web of Science ®Google Scholar
• AksoyBAltaykan-HapaAEgemenDKaragözFAtakanNThe impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalitiesBr J Dermatol2010163471972520545683
   PubMed Web of Science ®Google Scholar
• FinlayAYKhanGKDermatology life quality index (DLQI) – a simple practical measure for routine clinical useClin Exp Dermatol19941932102168033378
   PubMed Web of Science ®Google Scholar
• NicholsonKAbramovaLChrenMMYeungJChonSYChenSCA pilot quality-of-life instrument for acne rosaceaJ Am Acad Dermatol200757221322117445948
   PubMed Web of Science ®Google Scholar
• ShimTNAbdullahHThe effect of pulsed dye laser on the dermatology life quality index in erythematotelangiectatic rosacea patients: an assessmentJ Clin Aesthet Dermatol201364303223630639
   PubMedGoogle Scholar
• MenezesNMoreiraAMotaGBaptistaAQuality of life and rosacea: pulsed dye laser impactJ Cosmet Laser Ther200911313914119462330
   PubMed Web of Science ®Google Scholar
• DayanSHPritzkerRNArkinsJPA new treatment regimen for rosacea: onabotulinumtoxinAJ Drugs Dermatol20121112e76e7923377526
   PubMed Web of Science ®Google Scholar
• YuraitisMJacobCIBotulinum toxin for the treatment of facial flushingDermatol Surg200430110210414692937
   PubMed Web of Science ®Google Scholar